{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:06:16Z","timestamp":1795205176171,"version":"4.10.3"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["TRAN1-10416"],"award-info":[{"award-number":["TRAN1-10416"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-12590"],"award-info":[{"award-number":["DISC2-12590"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["ARO73170"],"award-info":[{"award-number":["ARO73170"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We present Dystrophic Epidermolysis Bullosa Cell Therapy (DEBCT), a scalable platform producing autologous organotypic iPS cell-derived induced skin composite (iSC) grafts for definitive treatment. Clinical-grade manufacturing integrates CRISPR-mediated genetic correction with reprogramming into one step, accelerating derivation of\n                    <jats:italic>COL7A1<\/jats:italic>\n                    -edited iPS cells from patients. Differentiation into epidermal, dermal and melanocyte progenitors is followed by CD49f-enrichment, minimizing maturation heterogeneity. Mouse xenografting of iSCs from four patients with different mutations demonstrates disease modifying activity at 1 month. Next-generation sequencing, biodistribution and tumorigenicity assays establish a favorable safety profile at 1-9 months. Single cell transcriptomics reveals that iSCs are composed of the major skin cell lineages and include prominent holoclone stem cell-like signatures of keratinocytes, and the recently described Gibbin-dependent signature of fibroblasts. The latter correlates with enhanced graftability of iSCs. In conclusion, DEBCT overcomes manufacturing and safety roadblocks and establishes a reproducible, safe, and cGMP-compatible therapeutic approach to heal lesions of DEB patients.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-49400-z","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T13:01:38Z","timestamp":1720702898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa"],"prefix":"10.1038","volume":"15","author":[{"given":"Gernot","family":"Neumayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1569-803X","authenticated-orcid":false,"given":"Jessica L.","family":"Torkelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-3525","authenticated-orcid":false,"given":"Shengdi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanson H.","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7271-2689","authenticated-orcid":false,"given":"Madhuri","family":"Vangipuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-9672","authenticated-orcid":false,"given":"Marius M.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulilat","family":"Gebeyehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taysir M.","family":"Jaouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-7896","authenticated-orcid":false,"given":"Joanna","family":"Jack\u00f3w-Malinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5509-6033","authenticated-orcid":false,"given":"Avina","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Gaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri M.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-2552","authenticated-orcid":false,"given":"Alberto","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8799-6207","authenticated-orcid":false,"given":"Kevin R.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuylinh Michelle","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-371X","authenticated-orcid":false,"given":"Patrick S.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganna","family":"Bilousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-5880","authenticated-orcid":false,"given":"Dennis","family":"Roop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Christiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3962-2865","authenticated-orcid":false,"given":"Lars M.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5309-515X","authenticated-orcid":false,"given":"Marius","family":"Wernig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-138X","authenticated-orcid":false,"given":"Anthony E.","family":"Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"49400_CR1","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1182\/blood.2019000949","volume":"134","author":"E Magrin","year":"2019","unstructured":"Magrin, E., Miccio, A. & Cavazzana, M. Lentiviral and genome-editing strategies for the treatment of beta-hemoglobinopathies. Blood 134, 1203\u20131213 (2019).","journal-title":"Blood"},{"key":"49400_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28762-2","volume":"13","author":"F Tucci","year":"2022","unstructured":"Tucci, F., Galimberti, S., Naldini, L., Valsecchi, M. G. & Aiuti, A. A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders. Nat. Commun. 13, 1315 (2022).","journal-title":"Nat. Commun."},{"key":"49400_CR3","doi-asserted-by":"crossref","unstructured":"Lee, A., Xu, J., Wen, Z. & Jin, P. Across dimensions: developing 2D and 3D human iPSC-based models of fragile X syndrome. Cells 11, 1725 (2022).","DOI":"10.3390\/cells11111725"},{"key":"49400_CR4","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1161\/CIRCRESAHA.122.320305","volume":"130","author":"D Thomas","year":"2022","unstructured":"Thomas, D., Choi, S., Alamana, C., Parker, K. K. & Wu, J. C. Cellular and engineered organoids for cardiovascular models. Circ. Res. 130, 1780\u20131802 (2022).","journal-title":"Circ. Res."},{"key":"49400_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2022.101944","volume":"75","author":"O Trush","year":"2022","unstructured":"Trush, O. & Takasato, M. Kidney organoid research: current status and applications. Curr. Opin. Genet. Dev. 75, 101944 (2022).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"49400_CR6","doi-asserted-by":"crossref","unstructured":"Rao, I., Crisafulli, L., Paulis, M. & Ficara, F. Hematopoietic cells from pluripotent stem cells: hope and promise for the treatment of inherited blood disorders. Cells 11, 557 (2022).","DOI":"10.3390\/cells11030557"},{"key":"49400_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.molmed.2019.07.004","volume":"25","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj, S., Kyba, M. & Perlingeiro, R. C. R. Pluripotent stem cell-based therapeutics for muscular dystrophies. Trends Mol. Med. 25, 803\u2013816 (2019).","journal-title":"Trends Mol. Med."},{"key":"49400_CR8","doi-asserted-by":"publisher","first-page":"264ra163","DOI":"10.1126\/scitranslmed.3009540","volume":"6","author":"V Sebastiano","year":"2014","unstructured":"Sebastiano, V. et al. Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci. Transl. Med. 6, 264ra163 (2014).","journal-title":"Sci. Transl. Med."},{"key":"49400_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236 (2020).","journal-title":"Nature"},{"key":"49400_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka, S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell 27, 523\u2013531 (2020).","journal-title":"Cell Stem Cell"},{"key":"49400_CR11","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/pde.14802","volume":"38","author":"S Fulchand","year":"2021","unstructured":"Fulchand, S. et al. Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: a global cross-sectional survey. Pediatr. Dermatol. 38, 1198\u20131201 (2021).","journal-title":"Pediatr. Dermatol."},{"key":"49400_CR12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jaad.2021.09.065","volume":"86","author":"GS Phillips","year":"2022","unstructured":"Phillips, G. S. et al. A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa. J. Am. Acad. Dermatol. 86, 1063\u20131071 (2022).","journal-title":"J. Am. Acad. Dermatol."},{"key":"49400_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"JY Tang","year":"2021","unstructured":"Tang, J. Y. et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet. J. Rare Dis. 16, 175 (2021).","journal-title":"Orphanet. J. Rare Dis."},{"key":"49400_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature24487","volume":"551","author":"T Hirsch","year":"2017","unstructured":"Hirsch, T. et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature 551, 327\u2013332 (2017).","journal-title":"Nature"},{"key":"49400_CR15","doi-asserted-by":"crossref","unstructured":"Kocher, T., Petkovic, I., Bischof, J. & Koller, U. Current developments in gene therapy for epidermolysis bullosa. Expert Opin. Biol. Ther. 22, 1137\u20131150 (2022).","DOI":"10.1080\/14712598.2022.2049229"},{"key":"49400_CR16","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jama.2016.15588","volume":"316","author":"Z Siprashvili","year":"2016","unstructured":"Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808\u20131817 (2016).","journal-title":"JAMA"},{"key":"49400_CR17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/nm1504","volume":"12","author":"F Mavilio","year":"2006","unstructured":"Mavilio, F. et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat. Med. 12, 1397\u20131402 (2006).","journal-title":"Nat. Med."},{"key":"49400_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5582\/irdr.2017.01005","volume":"6","author":"E Rashidghamat","year":"2017","unstructured":"Rashidghamat, E. & McGrath, J. A. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. Intractable Rare Dis. Res. 6, 6\u201320 (2017).","journal-title":"Intractable Rare Dis. Res."},{"key":"49400_CR19","doi-asserted-by":"crossref","unstructured":"Eichstadt, S. et al. Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight 4, e130554 (2019).","DOI":"10.1172\/jci.insight.130554"},{"key":"49400_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608653","volume":"11","author":"E Blanco","year":"2020","unstructured":"Blanco, E., Izotova, N., Booth, C. & Thrasher, A. J. Immune reconstitution after gene therapy approaches in patients with X-linked severe combined immunodeficiency disease. Front. Immunol. 11, 608653 (2020).","journal-title":"Front. Immunol."},{"key":"49400_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.omtm.2021.10.003","volume":"23","author":"T Uchiyama","year":"2021","unstructured":"Uchiyama, T. et al. Nonconditioned ADA-SCID gene therapy reveals ADA requirement in the hematopoietic system and clonal dominance of vector-marked clones. Mol. Ther. Methods Clin. Dev. 23, 424\u2013433 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"49400_CR22","doi-asserted-by":"crossref","unstructured":"Jackow, J. et al. CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells. Proc. Natl. Acad. Sci. USA 116, 26846\u201326852 (2019).","DOI":"10.1073\/pnas.1907081116"},{"key":"49400_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03190-3","volume":"9","author":"I Kogut","year":"2018","unstructured":"Kogut, I. et al. High-efficiency RNA-based reprogramming of human primary fibroblasts. Nat. Commun. 9, 745 (2018).","journal-title":"Nat. Commun."},{"key":"49400_CR24","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1002\/ajmg.a.62456","volume":"185","author":"EM Warshauer","year":"2021","unstructured":"Warshauer, E. M. et al. Ancestral patterns of recessive dystrophic epidermolysis bullosa mutations in Hispanic populations suggest Sephardic ancestry. Am. J. Med. Genet. A 185, 3390\u20133400 (2021).","journal-title":"Am. J. Med. Genet. A"},{"key":"49400_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.devcel.2013.05.017","volume":"26","author":"C Gunschmann","year":"2013","unstructured":"Gunschmann, C. et al. Insulin\/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. Dev. Cell 26, 176\u2013187 (2013).","journal-title":"Dev. Cell"},{"key":"49400_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0168-9525(00)89074-5","volume":"11","author":"OG Kelly","year":"1995","unstructured":"Kelly, O. G. & Melton, D. A. Induction and patterning of the vertebrate nervous system. Trends Genet. 11, 273\u2013278 (1995).","journal-title":"Trends Genet."},{"key":"49400_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/dvdy.24281","volume":"244","author":"A Li","year":"2015","unstructured":"Li, A. et al. Deciphering principles of morphogenesis from temporal and spatial patterns on the integument. Dev. Dyn. 244, 905\u2013920 (2015).","journal-title":"Dev. Dyn."},{"key":"49400_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41586-022-04727-9","volume":"606","author":"A Collier","year":"2022","unstructured":"Collier, A. et al. Gibbin mesodermal regulation patterns epithelial development. Nature 606, 188\u2013196 (2022).","journal-title":"Nature"},{"key":"49400_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-020-2352-3","volume":"582","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Hair-bearing human skin generated entirely from pluripotent stem cells. Nature 582, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"49400_CR30","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s41588-018-0263-0","volume":"50","author":"JM Pattison","year":"2018","unstructured":"Pattison, J. M. et al. Retinoic acid and BMP4 cooperate with p63 to alter chromatin dynamics during surface epithelial commitment. Nat. Genet. 50, 1658\u20131665 (2018).","journal-title":"Nat. Genet."},{"key":"49400_CR31","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1242\/dev.093948","volume":"140","author":"AM Tadeu","year":"2013","unstructured":"Tadeu, A. M. & Horsley, V. Notch signaling represses p63 expression in the developing surface ectoderm. Development 140, 3777\u20133786 (2013).","journal-title":"Development"},{"key":"49400_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbrc.2007.12.077","volume":"367","author":"R Hayashi","year":"2008","unstructured":"Hayashi, R. et al. Enrichment of corneal epithelial stem\/progenitor cells using cell surface markers, integrin alpha6 and CD71. Biochem. Biophys. Res. Commun. 367, 256\u2013263 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"49400_CR33","doi-asserted-by":"crossref","unstructured":"Metral, E., Bechetoille, N., Demarne, F., Rachidi, W. & Damour, O. alpha6 Integrin (alpha6(high))\/transferrin receptor (CD71)(low) keratinocyte stem cells are more potent for generating reconstructed skin epidermis than rapid adherent cells. Int. J. Mol. Sci. 18, 282 (2017).","DOI":"10.3390\/ijms18020282"},{"key":"49400_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.devcel.2018.11.032","volume":"48","author":"K Gupta","year":"2019","unstructured":"Gupta, K. et al. Single-cell analysis reveals a hair follicle dermal niche molecular differentiation trajectory that begins prior to morphogenesis. Dev. Cell 48, 17\u201331 e16 (2019).","journal-title":"Dev. Cell"},{"key":"49400_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","volume":"182","author":"AL Ji","year":"2020","unstructured":"Ji, A. L. et al. Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma. Cell 182, 497\u2013514 e422 (2020).","journal-title":"Cell"},{"key":"49400_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jid.2017.07.849","volume":"138","author":"T Kawakami","year":"2018","unstructured":"Kawakami, T. et al. Approach for the derivation of melanocytes from induced pluripotent stem cells. J. Investig. Dermatol. 138, 150\u2013158 (2018).","journal-title":"J. Investig. Dermatol."},{"key":"49400_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19234-6","volume":"11","author":"Z Lin","year":"2020","unstructured":"Lin, Z. et al. Murine interfollicular epidermal differentiation is gradualistic with GRHL3 controlling progression from stem to transition cell states. Nat. Commun. 11, 5434 (2020).","journal-title":"Nat. Commun."},{"key":"49400_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18075-7","volume":"11","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Single cell transcriptomics of human epidermis identifies basal stem cell transition states. Nat. Commun. 11, 4239 (2020).","journal-title":"Nat. Commun."},{"key":"49400_CR39","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1073\/pnas.84.8.2302","volume":"84","author":"Y Barrandon","year":"1987","unstructured":"Barrandon, Y. & Green, H. Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl. Acad. Sci. USA 84, 2302\u20132306 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"49400_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22779-9","volume":"12","author":"E Enzo","year":"2021","unstructured":"Enzo, E. et al. Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells. Nat. Commun. 12, 2505 (2021).","journal-title":"Nat. Commun."},{"key":"49400_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/cpsc.50","volume":"45","author":"N Gupta","year":"2018","unstructured":"Gupta, N. et al. CRISPR\/Cas9-based targeted genome editing for the development of monogenic diseases models with human pluripotent stem cells. Curr. Protoc. Stem Cell Biol. 45, e50 (2018).","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"49400_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81297-2","volume":"11","author":"V Aprilyanto","year":"2021","unstructured":"Aprilyanto, V., Aditama, R., Tanjung, Z. A., Utomo, C. & Liwang, T. CROP: a CRISPR\/Cas9 guide selection program based on mapping guide variants. Sci. Rep. 11, 1504 (2021).","journal-title":"Sci. Rep."},{"key":"49400_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41586-018-0500-9","volume":"561","author":"P Akcakaya","year":"2018","unstructured":"Akcakaya, P. et al. In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature 561, 416\u2013419 (2018).","journal-title":"Nature"},{"key":"49400_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nmeth.4278","volume":"14","author":"SQ Tsai","year":"2017","unstructured":"Tsai, S. Q. et al. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets. Nat. Methods 14, 607\u2013614 (2017).","journal-title":"Nat. Methods"},{"key":"49400_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jdcr.2017.09.036","volume":"3","author":"ED Cai","year":"2017","unstructured":"Cai, E. D. & Kim, J. Identification of novel targetable mutations in metastatic anorectal melanoma by next-generation sequencing. JAAD Case Rep. 3, 539\u2013541 (2017).","journal-title":"JAAD Case Rep."},{"key":"49400_CR46","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1101\/gad.1221804","volume":"18","author":"CA Callahan","year":"2004","unstructured":"Callahan, C. A. et al. MIM\/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription. Genes Dev. 18, 2724\u20132729 (2004).","journal-title":"Genes Dev."},{"key":"49400_CR47","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/mt.2013.290","volume":"22","author":"SP Melo","year":"2014","unstructured":"Melo, S. P. et al. Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant. Mol. Ther. 22, 725\u2013733 (2014).","journal-title":"Mol. Ther."},{"key":"49400_CR48","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.transproceed.2014.11.016","volume":"47","author":"JM Abellaneda","year":"2015","unstructured":"Abellaneda, J. M. et al. Validation of a quantitative polymerase chain reaction method for human Alu gene detection in microchimeric pigs used as donors for xenotransplantation. Transpl. Proc. 47, 132\u2013135 (2015).","journal-title":"Transpl. Proc."},{"key":"49400_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jpba.2014.07.037","volume":"100","author":"W Zhang","year":"2014","unstructured":"Zhang, W. et al. Development and qualification of a high sensitivity, high throughput Q-PCR assay for quantitation of residual host cell DNA in purification process intermediate and drug substance samples. J. Pharm. Biomed. Anal. 100, 145\u2013149 (2014).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"49400_CR50","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/onc.2009.500","volume":"29","author":"S Peng","year":"2010","unstructured":"Peng, S., Maihle, N. J. & Huang, Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29, 2153\u20132159 (2010).","journal-title":"Oncogene"},{"key":"49400_CR51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.stemcr.2022.02.014","volume":"17","author":"F Matheus","year":"2022","unstructured":"Matheus, F., Raveh, T., Oro, A. E., Wernig, M. & Drukker, M. Is hypoimmunogenic stem cell therapy safe in times of pandemics? Stem Cell Rep. 17, 711\u2013714 (2022).","journal-title":"Stem Cell Rep."},{"key":"49400_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm2351","volume":"9","author":"D Branzei","year":"2008","unstructured":"Branzei, D. & Foiani, M. Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol. 9, 297\u2013308 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"49400_CR53","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.ymthe.2021.02.019","volume":"29","author":"J Bonafont","year":"2021","unstructured":"Bonafont, J. et al. Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing. Mol. Ther. 29, 2008\u20132018 (2021).","journal-title":"Mol. Ther."},{"key":"49400_CR54","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","volume":"560","author":"F Adikusuma","year":"2018","unstructured":"Adikusuma, F. et al. Large deletions induced by Cas9 cleavage. Nature 560, E8\u2013E9 (2018).","journal-title":"Nature"},{"key":"49400_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09006-2","volume":"10","author":"G Cullot","year":"2019","unstructured":"Cullot, G. et al. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations. Nat. Commun. 10, 1136 (2019).","journal-title":"Nat. Commun."},{"key":"49400_CR56","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"49400_CR57","doi-asserted-by":"publisher","first-page":"8732","DOI":"10.1093\/nar\/gkab686","volume":"49","author":"M Liu","year":"2021","unstructured":"Liu, M. et al. Global detection of DNA repair outcomes induced by CRISPR-Cas9. Nucleic Acids Res. 49, 8732\u20138742 (2021).","journal-title":"Nucleic Acids Res."},{"key":"49400_CR58","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","volume":"28","author":"G Turchiano","year":"2021","unstructured":"Turchiano, G. et al. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell 28, 1136\u20131147 e1135 (2021).","journal-title":"Cell Stem Cell"},{"key":"49400_CR59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41421-019-0088-8","volume":"5","author":"J Yin","year":"2019","unstructured":"Yin, J. et al. Optimizing genome editing strategy by primer-extension-mediated sequencing. Cell Discov. 5, 18 (2019).","journal-title":"Cell Discov."},{"key":"49400_CR60","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cell.2020.10.025","volume":"183","author":"MV Zuccaro","year":"2020","unstructured":"Zuccaro, M. V. et al. Allele-specific chromosome removal after Cas9 cleavage in human embryos. Cell 183, 1650\u20131664 e1615 (2020).","journal-title":"Cell"},{"key":"49400_CR61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.stem.2018.12.012","volume":"24","author":"L Li","year":"2019","unstructured":"Li, L. et al. TFAP2C- and p63-dependent networks sequentially rearrange chromatin landscapes to drive human epidermal lineage commitment. Cell Stem Cell 24, 271\u2013284 e278 (2019).","journal-title":"Cell Stem Cell"},{"key":"49400_CR62","doi-asserted-by":"crossref","unstructured":"Schultz, L. et al. Identification of dual positive CD19+\/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report. J. Immunother. Cancer 8, e001073 (2020).","DOI":"10.1136\/jitc-2020-001073"},{"key":"49400_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14844-6","volume":"11","author":"B Werner","year":"2020","unstructured":"Werner, B. et al. Measuring single cell divisions in human tissues from multi-region sequencing data. Nat. Commun. 11, 1035 (2020).","journal-title":"Nat. Commun."},{"key":"49400_CR64","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).","journal-title":"Nucleic Acids Res."},{"key":"49400_CR65","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet, J. P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242\u2013W245 (2018).","journal-title":"Nucleic Acids Res."},{"key":"49400_CR66","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"49400_CR67","doi-asserted-by":"crossref","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10\u201312 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"49400_CR68","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"49400_CR69","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20, 1297\u20131303 (2010).","journal-title":"Genome Res"},{"key":"49400_CR70","doi-asserted-by":"crossref","unstructured":"Poplin, R. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/201178v3 (2018).","DOI":"10.1101\/201178"},{"key":"49400_CR71","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"49400_CR72","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","volume":"40","author":"A Wilm","year":"2012","unstructured":"Wilm, A. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 40, 11189\u201311201 (2012).","journal-title":"Nucleic Acids Res."},{"key":"49400_CR73","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1038\/nprot.2016.150","volume":"11","author":"H Fang","year":"2016","unstructured":"Fang, H. et al. Indel variant analysis of short-read sequencing data with Scalpel. Nat. Protoc. 11, 2529\u20132548 (2016).","journal-title":"Nat. Protoc."},{"key":"49400_CR74","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1101\/gr.9.8.677","volume":"9","author":"ST Sherry","year":"1999","unstructured":"Sherry, S. T., Ward, M. & Sirotkin, K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 9, 677\u2013679 (1999).","journal-title":"Genome Res."},{"key":"49400_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"49400_CR76","doi-asserted-by":"publisher","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","volume":"49","author":"C Gene Ontology","year":"2021","unstructured":"Gene Ontology, C. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 49, D325\u2013D334 (2021).","journal-title":"Nucleic Acids Res."},{"key":"49400_CR77","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"49400_CR78","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jid.2020.08.022","volume":"141","author":"J Jackow","year":"2021","unstructured":"Jackow, J. et al. Targeting the Jak\/signal transducer and activator of transcription 3 pathway with ruxolitinib in a mouse model of recessive dystrophic epidermolysis bullosa-squamous cell carcinoma. J. Investig. Dermatol. 141, 942\u2013946 (2021).","journal-title":"J. Investig. Dermatol."},{"key":"49400_CR79","doi-asserted-by":"publisher","first-page":"4A 8 1","DOI":"10.1002\/9780470151808.sc04a08s32","volume":"32","author":"RV Nelakanti","year":"2015","unstructured":"Nelakanti, R. V., Kooreman, N. G. & Wu, J. C. Teratoma formation: a tool for monitoring pluripotency in stem cell research. Curr. Protoc. Stem Cell Biol. 32, 4A 8 1\u20134A 8 17 (2015).","journal-title":"Curr. Protoc. Stem Cell Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49400-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T13:03:32Z","timestamp":1720703012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49400-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["49400"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-49400-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.T. is CEO of iPeace, Inc. M.W. is a scientific advisor for iPeace, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5834"}}